Business news, strategy, finance and company insights


Japanese multinational Fujifilm Corporation has chosen India as a base to test and refine a healthcare screening service model that will be developed into a global chain of artificial intelligence (AI)-driven preventive healthcare screening centers ) over the coming year.

Under the NURA brand, the group has already opened two centers that offer full-body AI-assisted medical screening in Bengaluru, Karnataka and Gurugram in the National Capital Region of Delhi. The screening program currently covers 15 major organ and lifestyle conditions, including cancers of the mouth, lung, colon, prostate, breast and cervix.

The company defines its testing centers as quite distinct from other diagnostic centers, as it aims to meet the preventive health care needs of healthy, asymptomatic people through specialized offerings. NURA also offers the first AI testing center in India. While a full body AI screening at NURA can cost ₹18,000 per person, tests carried out by other hospitals and diagnostic centers for the same purpose can cost double that, says Dr Tausif Ahmed Thangalvadi , medical director of NURA. Fujifilms’ proprietary technology makes testing safer (thanks to ultra-low dose radiation) and more accurate (thanks to Ai technology), he added.

The first NURA center was opened in Bengaluru in February 2021. While the second was opened in Gurugram on July 21, 2022, Fujifilm plans to announce its third center in Mumbai in September. The fourth should take place in Hyderabad. Teiichi Goto, President and CEO, Representative Director, Fujifilm Holdings Corporation, said the plan is to open 100 screening centers around the world in the coming years. The initial plan is to cover major Indian metros and countries in the Middle East and Southeast Asia. With each center expected to cost around $2 million, the company is looking for an investment of $200 million in the near future.

NURA centers are equipped with various medical devices from Fujifilm, including a CT and mammography system, as well as an AI-based medical informatics system that provides interpretation assistance to doctors and offers high-quality screening services. Japanese quality. The company aims to attract local residents and employees of major Indian companies to avail of their services. Daimler Truck, Mind Tree, Cholamandalam are among the business groups that have already opted for NURA services in Bengaluru, Dr Ahmed said.

“Ensuring the highest health standards in every region where we operate has been our top priority. We have a special connection to the Indian market; therefore, our aim is to ensure that medical screening services are readily available in the countries. We aim to position ourselves where access must be easier and regular screening must be achievable. We also plan to work with different companies to ensure that an essential aspect of preventive and regular health check-ups is not ignored by the country’s young working class,” Goto said.

Fujifilm’s Health Screening Services business in India has been recognized as part of the Indo-Pacific Supply Chain Resilience Projects promoted by Japan’s Ministry of Economy, Trade and industry, and has been hailed as an initiative that uses digital technology to help solve social problems in emerging economies. The project is to build a data coordination infrastructure based on blockchain technology to verify an AI-based mechanism to analyze screening data collected from the three NURA sites to provide feedback to NURA users.

NURA Centers are established through a 51:49 joint venture Fujifilm DKH, formed by Fujifilm and Kerala-based Dr. Kutty’s Healthcare.


Comments are closed.